Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers agrees to acquire YourBio Health, adding painless microneedle blood-sampling tech and expanding its at-home testing capabilities ahead…

Hims & Hers Health (HIMS) reported earnings 30 days ago. Whats next for the stock? We take a look at…

Hims & Hers Health (HIMS) reported earnings 30 days ago. Whats next for the stock? We take a look at…

Shares in telehealth company Hims Hers Health ($HIMS) flowed higher today as it bought blood sampling business YourBio Health.…

Hims & Hers Health (HIMS) has entered into an agreement to acquire YourBio Health, a Boston-based maker of capillary whole…

Hims & Hers to acquire YourBio Health for painless blood sampling tech…

Hims & Hers to acquire YourBio Health for painless blood sampling tech…

Hims & Hers to acquire YourBio Health for painless blood sampling tech…

SAN FRANCISCO & BOSTON, December 03, 2025--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today…

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into…

Acquisition Combines Hims Hers’ Leading Wellness Platform with YourBio’s Patented, Virtually Painless Micro-Needle Technology to Redefine the Future of…

Hims & Hers Health (HIMS) is attracting attention as investors size up its performance after recent share price movement. Over…

Cirrus Logic lands Bull of the Day as earnings beats and rising estimates contrast with pressure on peers like F5.…

For Immediate ReleaseChicago, IL – December 2, 2025 – Zacks Equity Research shares Cirrus Logic CRUS as the Bull of…

Cirrus Logic lands Bull of the Day as earnings beats and rising estimates contrast with pressure on peers like F5.…

As Hims & Hers stock slides on slowing growth and regulatory fears, a quiet stake in cancer-testing firm Grail is…

In recent days, Hims & Hers Health reported strong third-quarter revenue growth, introduced a US$250 million share buyback program, and…

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers and GoodRx are reshaping virtual care, but which one leads in platform strategy and patient engagement? Lets…

Hims & Hers and GoodRx are reshaping virtual care, but which one leads in platform strategy and patient engagement? Lets…

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and GoodRx Holdings, Inc.…

Shares of Hims & Hers Health (HIMS) recently climbed after the White House signaled plans to extend Obamacare subsidies, a…

Q3 Earnings Buzz: Recent chatter on X about Hims & Hers Health (HIMS) has been intense following their third-quarter earnings…

Hims & Hers Health, Inc. has authorised a $250 million share repurchase program, signalling confidence in its undervalued stock after…

In recent developments, Hims & Hers Health announced a new US$250 million share repurchase program, introduced its Labs health-testing service,…

Curious whether Hims & Hers Health is undervalued, overhyped, or a hidden gem? Let’s break down what recent moves and…

Hims & Hers Health (HIMS) Stock Jumps on Policy Tailwinds and Buyback Momentum — November 24, 2025 - TechStock²…

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers shows platform expansion, verticalization, new Labs offerings, slower FCF growth and strong long-term revenue targets. Learn why…